Literature DB >> 15941598

Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: a comparative study in two mouse strains.

Reena Haobam1, Kizhakke M Sindhu, Goutam Chandra, Kochupurackal P Mohanakumar.   

Abstract

Parkinson's disease (PD) is a common neurodegenerative disease that exhibits motor dysfunctions, such as tremor, akinesia and rigidity. In the present study, we investigated whether swim-test could be used as one of the behavioural monitoring techniques to study motor disability in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in two mouse strains, Balb/c and C57BL/6. Mice were treated with different doses of MPTP (10, 20 and 30 mg/kg, twice, 16 h apart), and were subjected to swim-test on the third day of the first MPTP injection. MPTP-induced tremor was monitored at 30 min, and akinesia and rigidity developed were studied 3 h after the second MPTP treatment. While tremor and akinesia produced were dose-dependent and the intensity of tremor was comparable in the two strains of mice studied, the latter response in C57BL/6 was significantly lesser than that observed in Balb/c. Rigidity exhibited in Balb/c mice were dose-dependent, but not in C57BL/6. There was observed an inverse relationship between swim-score and the doses of MPTP in both the strains. MPTP caused a significant and dose-dependent reduction in striatal dopamine level in both the strains of mice, when assayed on the fourth day employing an HPLC with electrochemical detector. A significant positive correlation existed (r = 0.94 for Balb/c and r = 0.82 for C57BL/6) for the striatal dopamine-depletion and the swim-score in the MPTP-treated mice. While swim deficit and striatal dopamine loss were long lasting (till the third week) in C57BL/6, in Balb/c mice the motor deficit showed recovery by the second week. In these animals, a significant attenuation in striatal dopamine loss was observed by the third week. These results indicate that swim ability is directly proportional to striatal dopamine content, and suggest that swim-test could be used as a major technique to monitor motor dysfunction in experimental animals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15941598     DOI: 10.1016/j.bbr.2005.04.011

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  28 in total

1.  Natural toxins implicated in the development of Parkinson's disease.

Authors:  Mohamed Salama; Oscar Arias-Carrión
Journal:  Ther Adv Neurol Disord       Date:  2011-11       Impact factor: 6.570

2.  Antiparkinsonian effects of aqueous methanolic extract of Hyoscyamus niger seeds result from its monoamine oxidase inhibitory and hydroxyl radical scavenging potency.

Authors:  T Sengupta; J Vinayagam; N Nagashayana; B Gowda; P Jaisankar; K P Mohanakumar
Journal:  Neurochem Res       Date:  2010-10-23       Impact factor: 3.996

3.  Exercise effects on motor and affective behavior and catecholamine neurochemistry in the MPTP-lesioned mouse.

Authors:  Lori M Gorton; Marta G Vuckovic; Nina Vertelkina; Giselle M Petzinger; Michael W Jakowec; Ruth I Wood
Journal:  Behav Brain Res       Date:  2010-05-21       Impact factor: 3.332

4.  The effect of docosahexaenoic Acid on visual evoked potentials in a mouse model of Parkinson's disease: the role of cyclooxygenase-2 and nuclear factor kappa-B.

Authors:  Ozlem Ozsoy; Gamze Tanriover; Narin Derin; Nimet Uysal; Necdet Demir; Burcu Gemici; Ceren Kencebay; Piraye Yargicoglu; Aysel Agar; Mutay Aslan
Journal:  Neurotox Res       Date:  2011-01-14       Impact factor: 3.911

5.  Motor Function in MPTP-Treated Tree Shrews (Tupaia belangeri chinensis).

Authors:  Kai-Li Ma; Jia-Hong Gao; Zhang-Qiong Huang; Ying Zhang; De-Xuan Kuang; Qin-Fang Jiang; Yuan-Yuan Han; Cong Li; Wen-Guang Wang; Xiao-Yan Huang; Juan Xu; Pin-Fen Tong; Xing-Xiao Yin; Jie-Jie Dai
Journal:  Neurochem Res       Date:  2013-06-25       Impact factor: 3.996

6.  Embryonic stem cells derived neuron transplantation recovery in models of parkinsonism in relation to severity of the disorder in rats.

Authors:  Reena Haobam; Debasmita Tripathy; Navneet A Kaidery; Kochupurackal P Mohanakumar
Journal:  Rejuvenation Res       Date:  2015-04       Impact factor: 4.663

7.  Effect of intranasal stem cell administration on the nigrostriatal system in a mouse model of Parkinson's disease.

Authors:  Mohamed Salama; Mahmoud Sobh; Mahmoud Emam; Ahmed Abdalla; Dina Sabry; Mohamed El-Gamal; Ahmed Lotfy; Mahmoud El-Husseiny; Mohamed Sobh; Ali Shalash; Wael My Mohamed
Journal:  Exp Ther Med       Date:  2017-01-20       Impact factor: 2.447

Review 8.  A review: traditional herbs and remedies impacting pathogenesis of Parkinson's disease.

Authors:  Vishavdeep Sharma; Onkar Bedi; Manisha Gupta; Rahul Deshmukh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-03-08       Impact factor: 3.000

9.  Quantitative measurement of postural sway in mouse models of human neurodegenerative disease.

Authors:  D Hutchinson; V Ho; M Dodd; H N Dawson; A C Zumwalt; D Schmitt; C A Colton
Journal:  Neuroscience       Date:  2007-07-21       Impact factor: 3.590

10.  Parkinson's disease: is it a toxic syndrome?

Authors:  Seham A Gad Elhak; Abdel Aziz A Ghanem; Hassan Abdelghaffar; Sahar El Dakroury; Mohamed M Salama
Journal:  Neurol Res Int       Date:  2010-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.